Traphaco JSC (HOSE: TRA)

Market Cap	3.13T
Revenue (ttm)	2.32T
Net Income (ttm)	184.85B
Shares Out	41.45M
EPS (ttm)	4,459.17
PE Ratio	16.93
Forward PE	n/a
Dividend	3,000.00 (3.98%)
Ex-Dividend Date	Jun 17, 2024

Volume	100
Open	75,400
Previous Close	76,500
Day's Range	75,400 - 75,400
52-Week Range	75,000 - 90,000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About Traphaco JSC

Traphaco Joint Stock Company, together with its subsidiaries, produces and trades in pharmaceutical products, chemicals, and medical supplies and equipment in Vietnam. Its pharmaceutical products include vitamins and minerals, sedatives, herbal supplements, anti-inflammatory drugs, mouth-nose-throat drugs, drugs used in eye, topical treatment, analgesics and anti-inflammatory, brain supplements, antihistamines, parasitic drugs, antifungals, antibiotics, antiviral drugs, gynecological medicines, insecticides, cardiovascular medicines, gastrointe...

• Industry: Pharmaceutical Preparations
• Founded: 1972
• Employees: 1,481
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: TRA

Financial Performance

In 2023, Traphaco JSC's revenue was 2.30 trillion, a decrease of -4.16% compared to the previous year's 2.40 trillion. Earnings were 229.44 billion, a decrease of -2.44%.